We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best ...

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $166.09, denoting a +1.44% change from the preceding trading day.

In the last few weeks, we’ve talked a lot about “hated” dividends set to soar as mainstream investors get it wrong on Trump 2 ...

Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK ...

Stock markets once again proved that they are pricing in problems ahead. On Tuesday, the Conference Board’s Consumer ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

For investors seeking a balance of risk management and income, a mix of low-volatility, high-dividend stocks can be a smart ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price objective cut by research analysts at The Goldman Sachs Group from $43.00 to $38.00 in a report released on Monday,Benzinga ...

DTD offers a dividend-weighted portfolio with significant exposure to technology. Read more to see my recommendation for the ...

Driven by innovative creator tool releases, Vimeo (VMEO) has managed to establish its dominance in the highly contested video ...